Clinical Trial Update: Acamprosate Safe to Use in Individuals With Liver Disease. [Phase 2]

View source ↗

Summary

A Phase 2 trial suggests acamprosate is safe to use in individuals with liver disease for alcohol-related liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol-related Liver Disease

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: Mayo Clinic | Conditions: Alcohol-related Liver Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-12-20